Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer

por Baba, Y, Nosho, K, Shima, K, Meyerhardt, J A, Chan, A T, Engelman, J A, Cantley, L C, Loda, M, Giovannucci, E, Fuchs, C S, Ogino, S
Publicado 2010

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

por Ng, K, Wolpin, B M, Meyerhardt, J A, Wu, K, Chan, A T, Hollis, B W, Giovannucci, E L, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2009

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer

por Ng, K, Wolpin, B M, Meyerhardt, J A, Wu, K, Chan, A T, Hollis, B W, Giovannucci, E L, Stampfer, M J, Willett, W C, Fuchs, C S
Publicado 2010

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

por Strosberg, J R, Chan, J A, Ryan, D P, Meyerhardt, J A, Fuchs, C S, Abrams, T, Regan, E, Brady, R, Weber, J, Campos, T, Kvols, L K, Kulke, M H
Publicado 2013

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer

por Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Earle, C. C., Kulke, M. H., Meyerhardt, J. A., Blaszkowsky, L. S., Zhu, A. X., Fidias, P., Vincitore, M. M., Mayer, R. J., Fuchs, C. S.
Publicado 2009

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

por Souglakos, J, Philips, J, Wang, R, Marwah, S, Silver, M, Tzardi, M, Silver, J, Ogino, S, Hooshmand, S, Kwak, E, Freed, E, Meyerhardt, J A, Saridaki, Z, Georgoulias, V, Finkelstein, D, Fuchs, C S, Kulke, M H, Shivdasani, R A
Publicado 2009

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma

por Chan, J. A., Blaszkowsky, L. S., Enzinger, P. C., Ryan, D. P., Abrams, T. A., Zhu, A. X., Temel, J. S., Schrag, D., Bhargava, P., Meyerhardt, J. A., Wolpin, B. M., Fidias, P., Zheng, H., Florio, S., Regan, E., Fuchs, C. S.
Publicado 2011

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

por Grothey, A., Sobrero, A.F., Shields, A.F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J.A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J.P., Renfro, L.A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M., Sargent, D.J., Andre, T., Iveson, T.
Publicado en N Engl J Med (2018)

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

por Fuchs, M. A., Yuan, C., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A., Atienza, D., Messino, M., Kindler, H., Venook, A., Innocenti, F., Warren, R. S., Bertagnolli, M. M., Ogino, S., Giovannucci, E. L., Horvath, E., Meyerhardt, J. A., Ng, K.
Publicado en Ann Oncol (2017)